| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |